AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E401752-T1: [Translated] METHOD AND ARRANGEMENT FOR PROVIDING A CONNECTION PATH TO A MOBILE RADIO NETWORK AND A SUITABLE TELECOMMUNICATIONS TERMINAL DEVICE FOR THIS

A method for setting up a connection path to a mobile RF network in which, as a connection path between a telecommunications terminal (1) and the access-and-switching units (9,10) of the mobile RF network a radio link (12), or a connection path (13) including the Internet (8) is automatically used, in which the Internet connection path (8,13) is handled as a further RF cell of the mobile RF network, by the access and switching-units (9,10,11), as well as the telecommunications terminal (1), with regard to the relationship with the switch-on of the telecommunications terminal (1) and its booking or log-on during sequences with the mobile RF network as well as a switch-over in the course of a changeover or hand-over of the connection path between the radio link (12) and Internet path (8,13) or vice versa.  Independent claims are included for (A) an arrangement for carrying out the method and (B) a telecommunications terminal for carrying out the method.
Elk Creek Seismic Waveforms 2012 (Part 12 of 20)

Coal bursts (damaging seismic events in underground coal mines) pose a substantial threat to operations and mine workers. The underground coal mines in Colorado’s North Fork Valley (NFV) have experienced many coal bursts, often with distinct characteristics from those of other US coal mining regions. To better understand these events and manage their associated risks, the National Institute for Occupational Safety and Health undertook a long-term monitoring campaign at the Elk Creek Mine in the NFV. The monitoring efforts included a seismic network composed of both surface and underground sensors, borehole pressure cells (BPCs), instrumented support Cans, convergence monitors, ground condition surveys, and several other data sources. This dataset consists of the event waveform files from the seismic network for the 983,379 events that were detected during the monitoring campaign. The waveforms are stored in HDF5 files that are broken up by week. Within the HDF5 files, the data are organized by station id, event time, and channel. The amplitudes are velocity in meters/second.
 
This is download 39 of 48 and corresponds to the time range between October 1, 2012, and October 8, 2012.
500 Cities: Local Data for Better Health, 2016 release

This is the complete dataset for the 500 Cities project 2016 release. This dataset includes 2013, 2014 model-based small area estimates for 27 measures of chronic disease related to unhealthy behaviors (5), health outcomes (13), and use of preventive services (9). Data were provided by the Centers for Disease Control and Prevention (CDC), Division of Population Health, Epidemiology and Surveillance Branch. The project was funded by the Robert Wood Johnson Foundation (RWJF) in conjunction with the CDC Foundation. It represents a first-of-its kind effort to release information on a large scale for cities and for small areas within those cities. It includes estimates for the 500 largest US cities and approximately 28,000 census tracts within these cities. These estimates can be used to identify emerging health problems and to inform development and implementation of effective, targeted public health prevention activities. Because the small area model cannot detect effects due to local interventions, users are cautioned against using these estimates for program or policy evaluations. Data sources used to generate these measures include Behavioral Risk Factor Surveillance System (BRFSS) data (2013, 2014), Census Bureau 2010 census population data, and American Community Survey (ACS) 2009-2013, 2010-2014 estimates. More information about the methodology can be found at www.cdc.gov/500cities.
Note: During the process of uploading the 2015 estimates, CDC found a data discrepancy in the published 500 Cities data for the 2014 city-level obesity crude prevalence estimates caused when reformatting the SAS data file to the open data format. . The small area estimation model and code were correct. This data discrepancy only affected the 2014 city-level obesity crude prevalence estimates on the Socrata open data file, the GIS-friendly data file, and the 500 Cities online application. The other obesity estimates (city-level age-adjusted and tract-level) and the Mapbooks were not affected. No other measures were affected. The correct estimates are update in this dataset on October 25, 2017.
Patent AT-E399583-T1: [Translated] ADJUSTABLE DUMBBELL WITH COMMERCIAL WEIGHTS

This invention relates to a selectorized dumbbell having a handle (4) that can be dropped down between nested left and right stacks of weight plates (32). The weight plates can comprise individual weights or a pair of weight plates, one from each stack, can be connected together to form a single weight (6). A selector (8) is provided to allow the user to select a desired number of weight plates from each stack and couple such weight plates to the handle to provide an adjustable weight dumbbell. Each weight includes a weight frame (20) having at least one carrier (30) to which a commodity weight can be fastened. The dumbbell can be shipped by the manufacturer with empty weight frames to reduce shipping costs. When the dumbbell with empty weight frames reaches a destination, the dumbbell can be completed by securing commodity weights to the carriers on the respective weight frames. <IMAGE> <IMAGE>
mRNA:guanine-N7 cap methyltransferases: identification of novel members of the family, evolutionary analysis, homology modeling, and analysis of sequence-structure-function relationships

The 5'-terminal cap structure plays an important role in many aspects of mRNA metabolism. Capping enzymes encoded by viruses and pathogenic fungi are attractive targets for specific inhibitors. There is a large body of experimental data on viral and cellular methyltransferases (MTases) that carry out guanine-N7 (cap 0) methylation, including results of extensive mutagenesis. However, a crystal structure is not available and cap 0 MTases are too diverged from other MTases of known structure to allow straightforward homology-based interpretation of these data.
Compound 526514: Ethyl 3-isothiocyanatopropionate

Chemical compound data from PubChem database. IUPAC Name: ethyl 3-isothiocyanatopropanoate. Molecular Formula: C6H9NO2S. Molecular Weight: 159.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2013 CMHS Uniform Reporting System (URS) Tables for Arizona

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Arizona for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 530077: 1,4-Dimethylhistidine, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 3-(3,5-dimethylimidazol-4-yl)-2-(trimethylsilylamino)propanoate. Molecular Formula: C14H29N3O2Si2. Molecular Weight: 327.57. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528663: Creatinine, TMS

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-N-trimethylsilyl-5-trimethylsilyloxy-4H-imidazol-2-imine. Molecular Formula: C10H23N3OSi2. Molecular Weight: 257.48. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530539: 4-Butylbenzoic acid, hexadecyl ester

Chemical compound data from PubChem database. IUPAC Name: hexadecyl 4-butylbenzoate. Molecular Formula: C27H46O2. Molecular Weight: 402.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528643: Trimethylsilyl 2-methyl-3-[(trimethylsilyl)oxy]pentanoate

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-methyl-3-trimethylsilyloxypentanoate. Molecular Formula: C12H28O3Si2. Molecular Weight: 276.52. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527523: Tetradecyl 2-bromobutanoate

Chemical compound data from PubChem database. IUPAC Name: tetradecyl 2-bromobutanoate. Molecular Formula: C18H35BrO2. Molecular Weight: 363.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525100: 1,3-Dichloroisopropyl nonanoate

Chemical compound data from PubChem database. IUPAC Name: 1,2-dichloropropan-2-yl nonanoate. Molecular Formula: C12H22Cl2O2. Molecular Weight: 269.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526396: 2,6-Dibromo,1,9-dichloro-dibenzo-dioxin

Chemical compound data from PubChem database. IUPAC Name: 2,6-dibromo-1,9-dichlorodibenzo-p-dioxin. Molecular Formula: C12H4Br2Cl2O2. Molecular Weight: 410.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
A Problem with the Individual Approach in the WHO Health Inequality Measurement

Background
          In the World Health Report 2000, the World Health Organization made the controversial choice to measure inequality across individuals rather than across groups, the standard in the field. This choice has been widely discussed and criticized.
        
        
          Discussion
          We look at the three questions: (1) is the World Health Organization's health inequality measure value-free as it claims? (2) if it is not, what is the normative position implied by its approach when measuring health inequality? and (3) is the individual approach a logically consistent methodological choice for that normative position?
        
        
          Summary
          We argue that the World Health Organization's health inequality measure is not value-free. If it was, the health inequality information that the measurement collected could not reasonably be included in its ranking of how well national health systems performed. The World Health Organization's normative position can be interpreted as a quite expansive view of justice, in which health distributions that have causes amenable to human intervention are considered to be matters of justice. Our conclusion is that if the World Health Organization's health inequality measure is to be interpreted meaningfully in a policy context, its conceptual underpinning must be re-evaluated.
COVID-19 State Profile Report - Ohio

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
DASH - Youth Risk Behavior Surveillance System (YRBSS): High School - Excluding Sexual Identity

1991-2017. High School Dataset. The Youth Risk Behavior Surveillance System (YRBSS) monitors six categories of priority health behaviors 
among youth and young adults: 1) behaviors that contribute to unintentional injuries and violence; 2) tobacco use; 3) alcohol and 
other drug use; 4) sexual behaviors related to unintended pregnancy and sexually transmitted infections (STIs), including human 
immunodeficiency virus (HIV) infection; 5) unhealthy dietary behaviors; and 6) physical inactivity. In addition, YRBSS monitors 
the prevalence of obesity and asthma and other priority health behaviors.
The emerging periplasm-localized subclass of AroQ chorismate mutases, exemplified by those from

Background
          Chorismate mutases of the AroQ homology class are widespread in the Bacteria and the Archaea. Many of these exist as domains that are fused with other aromatic-pathway catalytic domains. Among the monofunctional AroQ proteins, that from Erwinia herbicola was previously shown to have a cleavable signal peptide and located in the periplasmic compartment. Whether or not this might be unique to E. herbicola was unknown.
        
        
          Results
          The gene coding for the AroQ protein was cloned from Salmonella typhimurium, and the AroQ protein purified from both S. typhimurium and Pseudomonas aeruginosa was shown to have a periplasmic location. The periplasmic chorismate mutases (denoted *AroQ) are shown to be a distinct subclass of AroQ, being about twice the size of cytoplasmic AroQ proteins. The increased size is due to a carboxy-terminal extension of unknown function. In addition, a so-far novel aromatic aminotransferase was shown to be present in the periplasm of P. aeruginosa.
        
        
          Conclusions
          Our analysis has detected a number of additional *aroQ genes. The joint presence of *AroQ, cyclohexadienyl dehydratase and aromatic aminotransferase in the periplasmic compartment of P. aeruginosa comprises a complete chorismate-to-phenylalanine pathway and accounts for the "hidden overflow pathway" to phenylalanine described previously.
Development of Dengue virus type 2 replicons capable of prolonged expression in host cells

Background
          As part of a program to develop a Dengue virus vaccine which avoids the deleterious effects of antibody dependent enhancement (ADE) of infection mediated by antibodies to Dengue virus structural proteins, we have begun to investigate the possibility of designing Dengue vaccines based on non-structural proteins.
        
        
          Results
          Dengue constructs which lack major structural proteins replicate intracellularly in tissue culture. These replicons are capable of prolonged expression of Dengue virus non-structural proteins for at least seven days in culture.
        
        
          Conclusions
          Dengue virus genomes lacking major structural proteins can, like other flaviviruses, replicate intracellularly and express virus non-structural proteins with minimal toxicity to host cells. These findings pave the way for the development of dengue virus replicons as a form of live, attenuated virus vaccine.
Compound 527673: Butanoic acid, 2-chloro, 1,2-dimethylpropyl ester

Chemical compound data from PubChem database. IUPAC Name: 3-methylbutan-2-yl 2-chlorobutanoate. Molecular Formula: C9H17ClO2. Molecular Weight: 192.68. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy

Background
          Iron deficiency (ID) results in ventricular hypertrophy, believed to involve sympathetic stimulation. We hypothesized that with ID 1) intravenous norepinephrine would alter heart rate (HR) and contractility, 2) abdominal aorta would be larger and more distensible, and 3) the beta-blocker propanolol would reduce hypertrophy.
        
        
          Methods
          1) 30 CD rats were fed an ID or replete diet for 1 week or 1 month. Norepinephrine was infused via jugular vein; pressure was monitored at carotid artery. Saline infusions were used as a control. The pressure trace was analyzed for HR, contractility, systolic and diastolic pressures. 2) Abdominal aorta catheters inflated the aorta, while digital microscopic images were recorded at stepwise pressures to measure arterial diameter and distensibility. 3) An additional 10 rats (5 ID, 5 control) were given a daily injection of propanolol or saline. After 1 month, the hearts were excised and weighed.
        
        
          Results
          Enhanced contractility, but not HR, was associated with ID hypertrophic hearts. Systolic and diastolic blood pressures were consistent with an increase in arterial diameter associated with ID. Aortic diameter at 100 mmHg and distensibility were increased with ID. Propanolol was associated with an increase in heart to body mass ratio.
        
        
          Conclusions
          ID cardiac hypertrophy results in an increased inotropic, but not chronotropic response to the sympathetic neurotransmitter, norepinephrine. Increased aortic diameter is consistent with a flow-dependent vascular remodeling; increased distensibility may reflect decreased vascular collagen content. The failure of propanolol to prevent hypertrophy suggests that ID hypertrophy is not mediated via beta-adrenergic neurotransmission.
Compound 525123: Propanoic acid, 2,3-dichloropropylester

Chemical compound data from PubChem database. IUPAC Name: 2,3-dichloropropyl propanoate. Molecular Formula: C6H10Cl2O2. Molecular Weight: 185.05. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528192: 1,2-Propanediol, 3-(2-methylphenyloxy), DTBS

Chemical compound data from PubChem database. IUPAC Name: 2,2-ditert-butyl-4-(2-methylphenoxy)-1,3,2-dioxasilolane. Molecular Formula: C17H28O3Si. Molecular Weight: 308.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527125: 1,6-Dichloro-dibenzothiophene

Chemical compound data from PubChem database. IUPAC Name: 1,6-dichlorodibenzothiophene. Molecular Formula: C12H6Cl2S. Molecular Weight: 253.1. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529055: 2-Isopropyl-4,6-dimethyldihydro-1,3,5-dithiazine

Chemical compound data from PubChem database. IUPAC Name: 4,6-dimethyl-2-propan-2-yl-1,3,5-dithiazinane. Molecular Formula: C8H17NS2. Molecular Weight: 191.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2015 CMHS Uniform Reporting System (URS) Table for Maine

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Maine. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Patent AT-E400619-T1: [Translated] USE OF MOO3 AS A CORROSION INHIBITOR AND A COATING COMPOSITION CONTAINING SUCH AN INHIBITOR

Chemical patent from PubChem database. Patent Number: AT-E400619-T1. Title: Sustained Release Formulation. Filing Date: 1995-12-12. Inventors: Yamamoto, Hiroshi, Schmidt, Hans. Abstract: A sustained release formulation is provided, designed to maintain therapeutic drug levels over extended periods, reducing dosing frequency and improvi... IPC Classifications: A61K, A61P, C07D. This patent covers 29 claims related to 7 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Compound 525681: 4-Bromo-N-(4-chlorobenzylidene)aniline

Chemical compound data from PubChem database. IUPAC Name: N-(4-bromophenyl)-1-(4-chlorophenyl)methanimine. Molecular Formula: C13H9BrClN. Molecular Weight: 294.57. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526160: Dibutyl 4-cyano-phenyl phosphate

Chemical compound data from PubChem database. IUPAC Name: dibutyl (4-cyanophenyl) phosphate. Molecular Formula: C15H22NO4P. Molecular Weight: 311.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525655: p-Bromobenzylidene-(3-ethoxyphenyl)-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-bromophenyl)-N-(3-ethoxyphenyl)methanimine. Molecular Formula: C15H14BrNO. Molecular Weight: 304.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400284-T1: [Translated] AGENT FOR SUBSTITUTING BLOOD PLASMA AND PRODUCTION METHOD

The agent for substitution of the blood plasma is made up of the vegetal protein substance edestin, advantageously a product from the hemp seeds. Advantageously, edestin is a component of the solution comprised of 5%-40% in weight of edestin, 0.5%-7% in weight of inorganic substances, 0.5%-7% in weight of organic substances, hormones, and other substances to 100 % in weight of the colloid solution. According to the method of production of an agent for blood plasma substitution, the vegetal seeds are either cold-pressed or ground to powder and extracted under a compressed gas; the pressed out or extracted vegetal oil is separated, the pressed together or extracted seeds to be relieved of fat and decolorized are extracted by action of the organic solvents, the fat relieved and decolorized substance is then filtered out and exposed to action of the inorganic salts in the water solution and at the temperature from 20 ° C. to 60 ° C., the solution is filtered and edestin is finally isolated from the filtrate. Advantageousl hemp seeds are subjected to the cold pressing and grinding processes and to the gas-assisted pressure extraction. Advantageously, the vegetal seeds are being extracted under the compressed carbon dioxide.